You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

Article metrics

Article menu

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Short report
Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

 

Online download statistics by month:

Online download statistics by month: March 2020 to September 2024

AbstractFullPdf
Mar 202060606
Apr 2020415415134
May 202011311329
Jun 2020606069
Jul 2020454518
Aug 202016916918
Sep 2020676718
Oct 2020333317
Nov 2020373715
Dec 2020191915
Jan 2021535346
Feb 2021343417
Mar 2021373713
Apr 2021464621
May 2021313117
Jun 2021373722
Jul 2021222216
Aug 2021131311
Sep 2021161621
Oct 2021262633
Nov 2021393934
Dec 2021323216
Jan 2022313313
Feb 2022171913
Mar 2022313216
Apr 202233378
May 2022717115
Jun 202237378
Jul 202229309
Aug 2022343413
Sep 2022343419
Oct 2022363816
Nov 2022151713
Dec 202216164
Jan 2023993
Feb 2023424510
Mar 2023252610
Apr 2023141415
May 202314169
Jun 202311116
Jul 2023131310
Aug 202321227
Sep 202318188
Oct 2023272713
Nov 202314143
Dec 202319196
Jan 2024252611
Feb 2024232314
Mar 2024202052
Apr 2024202012
May 2024353713
Jun 2024141411
Jul 202427288
Aug 2024252517
Sep 2024141416
Total221822431007